FDA Adverse Event Malfunction Summary report: N

DIMENSION® CLINICAL CHEMISTRY SYSTEM

MDR report key: 2990458 · Received March 5, 2013

Report

Report Number
2517506-2013-00102
Event Type
Malfunction
Date Received
March 5, 2013
Date of Event
March 28, 2012
Report Date
February 8, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Product Code
JFY
PMA / PMN Number
K073055
Removal / Correction Number
2517506-02-22-2013-002-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HEALTHCARE DIAGNOSTICS INC. HAS CONFIRMED CUSTOMER COMPLAINTS OF FALSELY DEPRESSED ENZYMATIC CREATININE (EZCR) RESULTS WHEN EZCR IS PROCESSED FROM OPEN WELLS OF ENZYMATIC CREATININE (EZCR) FLEX REAGENT CARTRIDGES THAT ARE IN CLOSE PROXIMITY TO OPEN WELLS OF PHOSPHORUS (PHOS) FLEX REAGENT CARTRIDGES. THE FALSELY DEPRESSED EZCR RESULTS ARE CAUSED BY A EZCR REAGENT INTERACTION WITH THE PHOS REAGENT. AN URGENT MEDICAL DEVICE CORRECTION FOR THE PHOS FLEX REAGENT CARTRIDGE (DF61), COMMUNICATION #13-03 WAS ISSUED IN FEBRUARY 2013 TO IMPACTED CUSTOMERS. THE COMMUNICATION PROVIDED REMEDIAL ACTIONS TO CUSTOMERS TO EITHER AVOID THE REAGENT INTERACTIONS OR TO DISCONTINUE THE USE OF EITHER PHOS OR EZCR ON THEIR DIMENSION SYSTEM.

Description of Event or Problem · 1

FALSELY DEPRESSED ENZYMATIC CREATININE RESULTS WERE OBTAINED ON QC SAMPLES. IT IS UNKNOWN IF PATIENT RESULT WERE REPORTED TO THE PHYSICIAN. THE SAMPLES WERE REPEATED WITH A NEW REAGENT SEGMENT (WELL) AND HIGHER RESULTS WERE OBTAINED. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED AS A RESULT OF THE FALSELY DEPRESSED CREATININE QC RESULTS. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE FALSELY DEPRESSED CREATININE QC RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
93846 DIMENSION® CLINICAL CHEMISTRY SYSTEM ENZYMATIC CREATININE FLEX® REAGENT CARTRIDGE JFY SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW GA2351

Patients

Seq Age Sex Outcome Treatment
1